PharmaCyte Biotech (PMCB) Long-Term Investments (2013 - 2026)
PharmaCyte Biotech (PMCB) reported Long-Term Investments of $9.37 million for fiscal Q1 2027 (quarter ended Jul 31, 2026), down 52.3% from $19.64 million a year earlier.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Long-Term Investments (2013 - 2026) Analysis & Trends
At the end of FY2025 (ended Apr 30, 2025), PharmaCyte Biotech posted Long-Term Investments of $22.47 million.
- Long-Term Investments has a five-year compound annual growth rate of 70.2% (FY2020 to FY2025).
- By fiscal year, Long-Term Investments came in at $1.57 million in FY2023 (unchanged), $1.57 million in FY2022 (unchanged) and $1.57 million in FY2021 (unchanged).
- The fiscal Q1 2027 figure ranks as the lowest quarterly Long-Term Investments since fiscal Q3 2024.
- Year over year, Long-Term Investments gained in 1 of the last four quarters, with an average decline of 20.2%.
- The high point for year-over-year Long-Term Investments in five years was fiscal Q3 2026 (growth of 20.6%); the low point was fiscal Q1 2027 (a decline of 52.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 3.86 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | - |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 266.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 1.22 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 69.00 Mn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 297.00 Mn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | - |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 1.56 Bn |
| 10 | PharmaCyte Biotech | 3.79 Mn | -69.05 Mn | - | 9.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 9.37 Mn |
| Jan 31, 2026 | 22.47 Mn |
| Oct 31, 2025 | 20.75 Mn |
| Jul 31, 2025 | 19.64 Mn |
| Apr 30, 2025 | 22.47 Mn |
| Jan 31, 2025 | 18.63 Mn |
| Oct 31, 2024 | 24.86 Mn |
| Jul 31, 2024 | 29.12 Mn |
| Jan 31, 2024 | 1.57 Mn |
| Oct 31, 2023 | 1.57 Mn |
| Jul 31, 2023 | 1.57 Mn |
| Apr 30, 2023 | 1.57 Mn |
| Jan 31, 2023 | 1.57 Mn |
| Oct 31, 2022 | 1.57 Mn |
| Jul 31, 2022 | 1.57 Mn |
| Apr 30, 2022 | 1.57 Mn |
| Jan 31, 2022 | 1.57 Mn |
| Oct 31, 2021 | 1.57 Mn |
| Jul 31, 2021 | 1.57 Mn |
| Apr 30, 2021 | 1.57 Mn |
API Access
PharmaCyte Biotech Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();